Technical events and factor profile →
This 10-Q introduces no material changes to the risk factors vs. the latest annual report.
| Jun 26 | Mar 26 | Dec 25 | Sep 25 | Jun 25 | |
|---|---|---|---|---|---|
| Revenue | $145M | $389M | $678M | $1.0B | $142M |
| YoY growth | +2.1% | +260.2% | -29.8% | -45.4% | -41.1% |
| Gross margin | — | — | — | — | — |
| Operating margin | -562.1% | -356.8% | -126.4% | -25.6% | -638.7% |
| Net income | -$782M | -$1.3B | -$826M | -$200M | -$825M |
| Diluted EPS | -1.97 | -3.40 | -2.10 | -0.51 | -2.13 |
XBRL data filed with the SEC. The fourth fiscal quarter is calculated as the full year minus the previous three quarters.
0 = the lowest in the universe, 100 = the highest. It describes how the stock has behaved, not whether to buy or sell it. Screen stocks by factors
| Bridgewater Associates · Ray Dalio
held since Q3 2025 |
0.0% | $807K | -85% |
Weight in each fund's portfolio and change vs. the previous quarter, from its latest 13F.
| 2026-10-15 | Hoge Stephen · President | Sell (10b5-1 plan) | $8.6M | SEC ↗ |
| 2026-10-14 | Hoge Stephen · President | Sell (10b5-1 plan) | $8.3M | SEC ↗ |
| 2026-10-14 | Hoge Stephen · President | Sell (10b5-1 plan) | $96K | SEC ↗ |
Source: SEC EDGAR. Automatic comparison of the risk factors section; it may contain extraction errors. Always check the original document. For information purposes only; not investment advice.